Medical School Headquarters

Save 25% on Summer MCAT Immersive Session 2  Use Code IMMERSIVE25

<

Highlight & Takeaways

Session 28

What happens when your dream of becoming a doctor is interrupted by a life- threatening diagnosis?

Join host Deana Golini as she interviews Ananya Bashyam, an M2 at Loyola Stritch School of Medicine, who survived three relapses of leukemia while completing her medical school applications and her first year of training. Ananya pulls back the curtain on the “dark side” of medicine, sharing the vulnerability of losing her identity as a healthy person and finding it again as a patient-advocate.

From navigating stem cell transplants and fertility preservation to carrying an immunotherapy pump in her white coat, Ananya’s story is a masterclass in grit. She discusses the systemic issues in the bone marrow registry for people of color and why “scraped by” was a victory worth celebrating during the hardest year of her life.

If Ananya’s journey provides the clarity you need for your residency path, like this video, share your thoughts in the comments, and subscribe for more insider blueprints for med school success!

Explore additional resources:

Main website: https://medschoolyears.com

Apply to be on the podcast: https://airtable.com/app3Id0NacMjivHH…

Full show notes coming soon!

You might also like

loading

BSDO Over MD: Why Riya Chose the Osteopathic Combined Program

Session 625 Riya knew she wanted to be a doctor before she could fully explain...

From 506 to Navy HPSP: A Reapplicant’s Reset

Session 624 Kiki didn’t have a dramatic origin story—no early illness or single defining moment....

Second-Time Applicant: COVID Delay, Perspective, Acceptance

Session 623 Vanessa’s path to medicine started with a childhood ear-cleaning ritual and grew through...

From 495 MCAT to Med School via a Bridge Program

Session 622 Zarak shares how he walked away from premed after a 495 MCAT and...

Never miss an episode!

Watch this video to learn how to subscribe to our Meded Podcasts.

What our listeners are saying

Lorem ipsum dolor sit amet, consectetur adipiscing elit